Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine L Youmans

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Experimental Neurology|June 14, 2012
TDP-43: a new player on the AD field?Katherine L Youmans, Benjamin Wolozin
Biochimica Et Biophysica Acta|May 18, 2010
Proposed mechanism for lipoprotein remodelling in the brainChunjiang Yu, Katherine L Youmans, Mary J LaDu
Neuroscience Letters|December 26, 2013
APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg miceJacqueline Kunzler, Katherine L Youmans, Chunjiang Yu, et al.
International Journal of Alzheimer'S Disease|October 27, 2011
Introducing Human APOE into Aβ Transgenic Mouse ModelsLeon M Tai, Katherine L Youmans, Lisa Jungbauer, et al.
Brain Research|August 10, 2014
Pathological stress granules in Alzheimer's diseasePeter E A Ash, Tara E Vanderweyde, Katherine L Youmans, et al.
The Journal of Biological Chemistry|October 13, 2012
APOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer diseaseKatherine L Youmans, Leon M Tai, Evelyn Nwabuisi-Heath, et al.
Molecular Neurodegeneration|March 20, 2012
Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibodyKatherine L Youmans, Leon M Tai, Takahisa Kanekiyo, et al.
The Journal of Biological Chemistry|January 8, 2013
Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samplesLeon M Tai, Tina Bilousova, Lisa Jungbauer, et al.
Human Molecular Genetics|May 6, 2014
A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicityJulien Dusonchet, Hu Li, Maria Guillily, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Experimental Neurology|June 14, 2012
TDP-43: a new player on the AD field?Katherine L Youmans, Benjamin Wolozin
Biochimica Et Biophysica Acta|May 18, 2010
Proposed mechanism for lipoprotein remodelling in the brainChunjiang Yu, Katherine L Youmans, Mary J LaDu
Neuroscience Letters|December 26, 2013
APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg miceJacqueline Kunzler, Katherine L Youmans, Chunjiang Yu, et al.
International Journal of Alzheimer'S Disease|October 27, 2011
Introducing Human APOE into Aβ Transgenic Mouse ModelsLeon M Tai, Katherine L Youmans, Lisa Jungbauer, et al.
Brain Research|August 10, 2014
Pathological stress granules in Alzheimer's diseasePeter E A Ash, Tara E Vanderweyde, Katherine L Youmans, et al.
The Journal of Biological Chemistry|October 13, 2012
APOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer diseaseKatherine L Youmans, Leon M Tai, Evelyn Nwabuisi-Heath, et al.
Molecular Neurodegeneration|March 20, 2012
Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibodyKatherine L Youmans, Leon M Tai, Takahisa Kanekiyo, et al.
The Journal of Biological Chemistry|January 8, 2013
Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samplesLeon M Tai, Tina Bilousova, Lisa Jungbauer, et al.
Human Molecular Genetics|May 6, 2014
A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicityJulien Dusonchet, Hu Li, Maria Guillily, et al.
Pageof 1